Contacts, documents and full notice history are available with a subscription.
Special Notice NONE Expired 1 notice 1 document

oligo primers ERP_PR_1301339767

Solicitation ERP_PR_1301339767 Copied Notice ID cddd9771b833496f8d1d83ab5280eff2 Copied DEPT OF DEFENSE — NAVAL MEDICAL RESEARCH CENTER
SAM.gov
Posted
Mar 11, 2026
Deadline
Mar 26, 2026
Set-aside
NONE
NAICS
334516
PSC
6640

Summary

AI-generated · Mar 12, 2026

Provide customized primers and probes designed for RT-qPCR molecular diagnostics of Dengue (four serotypes), Chikungunya, Zika, Mayaro, Hantavirus, Orthobunyavirus (Guaroa, Oropouche, Group C, Bunyamwera, California), Influenza A (matrix gene) and B and subtypes (H3, H1pdm/SwH1N1, H1 seasonal), and SARS-CoV-2. These primers/probes will be used in RT real-time PCR assays with serum, saliva, blood, and/or urine from febrile surveillance, as well as pharyngeal, rectal, and fecal swabs and egg culture samples from respiratory surveillance, and have been validated on the TaqMan 7500/7500 Fast Real-Time PCR and QuantStudio platforms. The real-time PCR assays have been developed independently for each SOP and require substantial laboratory time and supervisor approval.

Materials must remain exactly as specified in the SOPs; any deviation would necessitate redesign and re-validation, delaying processing and timely detection of public health pathogens. Shipments of the primers/probes should be sent to NAMRU-SOUTH promptly after award.

The Virology Department of the U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH) is seeking to purchase customized primers and probes designed to be used for molecular diagnosis of Dengue virus (four serotypes), Chikungunya virus, Zika virus, Mayaro virus, Hantavirus, Orthobunyavirus (including Guaroa, Oropouche, Group C, Bunyamwera and California viruses), Influenza virus (Influenza A-matrix gene and B) and its subtypes (H3, H1pdm/SwH1N1, H1 seasonal), and SARS-CoV-2. Requested primers and probes will be used for reverse transcription (RT) real-time PCR assays using serum, saliva, blood and/or urine samples from febrile surveillance protocols and pharyngeal swabs, rectal swabs, fecal samples and/or egg culture samples from respiratory surveillance protocols. All these NAMRU SOUTH assays have been validated using the TaqMan 7500/7500 Fast Real time PCR system and QuantStudio platforms. The real-time PCR assays have been developed independently for each SOP and involve much time and effort by laboratory technicians, and supervisors for final approval. Materials used must remain the same as the ones indicated in the SOPs, otherwise the design and validation of these processes would have to be initiated from scratch, which would delay all processing and the timely detection of public health relevant pathogens. Shipment of primers is expected to happen as soon as contract is awarded to the following address: NAMRU-SOUTH 3230 Lima Place Washington, DC 20521

From Special Notice posted on Mar 11, 2026

Notice history

1
  1. Special Notice LATEST Posted Mar 11, 2026

Details

Solicitation number ERP_PR_1301339767
Notice ID cddd9771b833496f8d1d83ab5280eff2
Notice type Special Notice
Product / Service (PSC) 6640
NAICS 334516
Set-aside No Set aside used
Place of performance LIMA
Archive date Apr 10, 2026

Award Information

Not yet awarded

Documents

1
View on SAM.gov

Contacts

primary
Genaro Vasquez

Email

Phone

Agency

DEPT OF DEFENSE
DEPT OF THE NAVY
NAVSUP
NAVSUP OTHER HCA
BUMED
NAVY MEDICINE WEST
NAVAL MEDICAL RESEARCH CENTER

Place of Performance

LIMA
PER

Dates

Posted Mar 11, 2026 4 months ago
Last Updated Aug 06, 2026 2 days ago
Due Mar 26, 2026 4 months ago